KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOther Non-Current AssetsPayablesReal Estate - GrossReal Estate - NetReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Cash & Equivalents (2016 - 2025)

Omega Healthcare Investors' Cash & Equivalents history spans 15 years, with the latest figure at $737.2 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 10636.76% year-over-year to $737.2 million; the TTM value through Sep 2025 reached $737.2 million, up 10636.76%, while the annual FY2024 figure was $518.3 million, 17.06% up from the prior year.
  • Cash & Equivalents for Q3 2025 was $737.2 million at Omega Healthcare Investors, roughly flat from $734.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $737.2 million in Q3 2025 and bottomed at $6.9 million in Q3 2024.
  • The 5-year median for Cash & Equivalents is $297.1 million (2022), against an average of $301.0 million.
  • The largest annual shift saw Cash & Equivalents crashed 98.76% in 2024 before it surged 10636.76% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $20.5 million in 2021, then skyrocketed by 1346.88% to $297.1 million in 2022, then skyrocketed by 49.04% to $442.8 million in 2023, then rose by 17.06% to $518.3 million in 2024, then surged by 42.22% to $737.2 million in 2025.
  • Per Business Quant, the three most recent readings for OHI's Cash & Equivalents are $737.2 million (Q3 2025), $734.2 million (Q2 2025), and $368.0 million (Q1 2025).